Concepts (364)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cognitive Dysfunction | 34 | 2023 | 1045 | 9.720 |
Why?
|
| Apolipoprotein E4 | 14 | 2023 | 256 | 4.470 |
Why?
|
| Alzheimer Disease | 19 | 2023 | 2137 | 3.700 |
Why?
|
| Cognition | 27 | 2023 | 1360 | 2.690 |
Why?
|
| Aged | 70 | 2023 | 9320 | 2.620 |
Why?
|
| Cognition Disorders | 14 | 2018 | 1021 | 2.620 |
Why?
|
| Stroke | 6 | 2023 | 278 | 2.530 |
Why?
|
| Female | 76 | 2023 | 15777 | 2.010 |
Why?
|
| Humans | 93 | 2023 | 28449 | 1.890 |
Why?
|
| Male | 66 | 2023 | 15352 | 1.870 |
Why?
|
| Apolipoproteins E | 8 | 2023 | 256 | 1.850 |
Why?
|
| Longitudinal Studies | 23 | 2022 | 1379 | 1.630 |
Why?
|
| Cohort Studies | 20 | 2023 | 1936 | 1.550 |
Why?
|
| Aging | 11 | 2023 | 1566 | 1.540 |
Why?
|
| Exercise | 9 | 2023 | 475 | 1.540 |
Why?
|
| White Matter | 3 | 2022 | 142 | 1.530 |
Why?
|
| Activities of Daily Living | 9 | 2018 | 611 | 1.520 |
Why?
|
| Biomarkers | 8 | 2023 | 594 | 1.490 |
Why?
|
| Population Surveillance | 3 | 2021 | 110 | 1.430 |
Why?
|
| Chicago | 20 | 2022 | 912 | 1.350 |
Why?
|
| Risk Factors | 21 | 2023 | 2414 | 1.340 |
Why?
|
| Aged, 80 and over | 30 | 2022 | 4881 | 1.270 |
Why?
|
| Vitamin E | 2 | 2023 | 45 | 1.270 |
Why?
|
| Intermediate Filaments | 4 | 2023 | 20 | 1.250 |
Why?
|
| Dementia | 8 | 2022 | 578 | 1.150 |
Why?
|
| Disease Progression | 11 | 2019 | 721 | 1.110 |
Why?
|
| Mortality | 4 | 2021 | 90 | 1.040 |
Why?
|
| tau Proteins | 3 | 2023 | 233 | 1.030 |
Why?
|
| Genotype | 6 | 2018 | 349 | 0.990 |
Why?
|
| Alleles | 8 | 2023 | 211 | 0.980 |
Why?
|
| Prospective Studies | 12 | 2023 | 1802 | 0.910 |
Why?
|
| Disability Evaluation | 4 | 2014 | 292 | 0.890 |
Why?
|
| Whole Grains | 1 | 2023 | 7 | 0.890 |
Why?
|
| Neuropathology | 3 | 2021 | 85 | 0.830 |
Why?
|
| Depression | 4 | 2014 | 458 | 0.800 |
Why?
|
| Vitamin D | 1 | 2022 | 41 | 0.780 |
Why?
|
| Incidence | 10 | 2023 | 772 | 0.780 |
Why?
|
| Antihypertensive Agents | 2 | 2021 | 72 | 0.750 |
Why?
|
| Neurodegenerative Diseases | 1 | 2023 | 121 | 0.750 |
Why?
|
| United States | 11 | 2023 | 2185 | 0.740 |
Why?
|
| Healthy Lifestyle | 4 | 2022 | 38 | 0.730 |
Why?
|
| Blood Pressure | 2 | 2021 | 204 | 0.720 |
Why?
|
| Neurofilament Proteins | 1 | 2020 | 10 | 0.720 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2020 | 37 | 0.710 |
Why?
|
| Membrane Proteins | 1 | 2021 | 177 | 0.690 |
Why?
|
| Geriatric Assessment | 5 | 2021 | 215 | 0.660 |
Why?
|
| Neuropsychological Tests | 11 | 2018 | 1257 | 0.600 |
Why?
|
| Time Factors | 10 | 2021 | 1499 | 0.590 |
Why?
|
| Diet | 4 | 2023 | 221 | 0.590 |
Why?
|
| Art | 1 | 2016 | 1 | 0.550 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2022 | 385 | 0.540 |
Why?
|
| Mental Status and Dementia Tests | 3 | 2023 | 70 | 0.540 |
Why?
|
| Music | 1 | 2016 | 24 | 0.540 |
Why?
|
| Diabetes Complications | 1 | 2016 | 59 | 0.530 |
Why?
|
| Models, Statistical | 2 | 2021 | 128 | 0.520 |
Why?
|
| Life Style | 5 | 2022 | 199 | 0.510 |
Why?
|
| Prevalence | 3 | 2023 | 476 | 0.490 |
Why?
|
| Obesity | 6 | 2014 | 322 | 0.490 |
Why?
|
| Mobility Limitation | 2 | 2015 | 95 | 0.480 |
Why?
|
| Cognitive Aging | 4 | 2021 | 79 | 0.480 |
Why?
|
| Body Mass Index | 6 | 2018 | 467 | 0.470 |
Why?
|
| Depressive Disorder | 1 | 2015 | 185 | 0.460 |
Why?
|
| Gene-Environment Interaction | 1 | 2014 | 18 | 0.460 |
Why?
|
| Follow-Up Studies | 10 | 2018 | 1870 | 0.460 |
Why?
|
| Memantine | 1 | 2014 | 9 | 0.450 |
Why?
|
| Dopamine Agents | 1 | 2014 | 16 | 0.450 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2016 | 190 | 0.450 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2021 | 288 | 0.440 |
Why?
|
| Genome-Wide Association Study | 5 | 2022 | 292 | 0.440 |
Why?
|
| Cardiovascular Diseases | 1 | 2017 | 370 | 0.430 |
Why?
|
| Antioxidants | 1 | 2014 | 65 | 0.430 |
Why?
|
| Motor Activity | 2 | 2015 | 332 | 0.420 |
Why?
|
| Health Status Disparities | 1 | 2013 | 75 | 0.410 |
Why?
|
| Memory, Episodic | 3 | 2018 | 116 | 0.400 |
Why?
|
| Diagnosis | 1 | 2011 | 24 | 0.390 |
Why?
|
| Area Under Curve | 1 | 2011 | 63 | 0.390 |
Why?
|
| Medical Informatics | 1 | 2011 | 10 | 0.380 |
Why?
|
| Linear Models | 3 | 2016 | 256 | 0.360 |
Why?
|
| Refusal to Participate | 1 | 2010 | 2 | 0.360 |
Why?
|
| Predictive Value of Tests | 3 | 2021 | 494 | 0.350 |
Why?
|
| Independent Living | 3 | 2022 | 312 | 0.350 |
Why?
|
| Disabled Persons | 1 | 2012 | 125 | 0.350 |
Why?
|
| Age of Onset | 3 | 2014 | 99 | 0.310 |
Why?
|
| Genetic Loci | 3 | 2018 | 54 | 0.310 |
Why?
|
| Middle Aged | 21 | 2019 | 9316 | 0.300 |
Why?
|
| Postmenopause | 7 | 2006 | 57 | 0.280 |
Why?
|
| Memory Disorders | 2 | 2018 | 169 | 0.270 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2022 | 1197 | 0.260 |
Why?
|
| Neuroticism | 2 | 2023 | 32 | 0.250 |
Why?
|
| Hypoglycemic Agents | 2 | 2016 | 40 | 0.240 |
Why?
|
| Survivors | 3 | 2022 | 72 | 0.240 |
Why?
|
| Diet, Mediterranean | 2 | 2022 | 96 | 0.220 |
Why?
|
| Florida | 1 | 2023 | 22 | 0.220 |
Why?
|
| Sex Factors | 2 | 2022 | 480 | 0.210 |
Why?
|
| Tocopherols | 1 | 2023 | 9 | 0.210 |
Why?
|
| alpha-Tocopherol | 1 | 2023 | 13 | 0.210 |
Why?
|
| Adult | 11 | 2023 | 8155 | 0.210 |
Why?
|
| Diet, Vegetarian | 1 | 2022 | 8 | 0.210 |
Why?
|
| Flavonols | 1 | 2022 | 11 | 0.210 |
Why?
|
| Regression Analysis | 4 | 2011 | 267 | 0.200 |
Why?
|
| Vitamins | 1 | 2022 | 21 | 0.200 |
Why?
|
| Brain Infarction | 1 | 2023 | 75 | 0.200 |
Why?
|
| Dietary Supplements | 1 | 2022 | 67 | 0.200 |
Why?
|
| Loneliness | 1 | 2023 | 59 | 0.200 |
Why?
|
| Life Expectancy | 1 | 2022 | 28 | 0.200 |
Why?
|
| Age Factors | 2 | 2022 | 796 | 0.200 |
Why?
|
| Dietary Approaches To Stop Hypertension | 1 | 2022 | 33 | 0.200 |
Why?
|
| Cognitive Reserve | 1 | 2022 | 39 | 0.200 |
Why?
|
| Renin-Angiotensin System | 1 | 2021 | 5 | 0.190 |
Why?
|
| Stress, Psychological | 2 | 2014 | 245 | 0.190 |
Why?
|
| Blood-Brain Barrier | 1 | 2021 | 39 | 0.180 |
Why?
|
| Cost of Illness | 1 | 2021 | 53 | 0.180 |
Why?
|
| Amyloid beta-Peptides | 1 | 2022 | 322 | 0.180 |
Why?
|
| Noise | 1 | 2020 | 31 | 0.180 |
Why?
|
| Early Diagnosis | 1 | 2020 | 68 | 0.180 |
Why?
|
| Mental Status Schedule | 2 | 2018 | 98 | 0.170 |
Why?
|
| Neuroimaging | 1 | 2020 | 133 | 0.170 |
Why?
|
| Cerebral Cortex | 1 | 2020 | 166 | 0.160 |
Why?
|
| Confidence Intervals | 2 | 2017 | 97 | 0.160 |
Why?
|
| Residence Characteristics | 1 | 2020 | 216 | 0.160 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2018 | 12 | 0.160 |
Why?
|
| Phototherapy | 1 | 2019 | 36 | 0.160 |
Why?
|
| Parkinsonian Disorders | 1 | 2022 | 227 | 0.160 |
Why?
|
| Social Networking | 1 | 2018 | 11 | 0.150 |
Why?
|
| Healthy Aging | 1 | 2018 | 14 | 0.150 |
Why?
|
| Hippocampus | 1 | 2020 | 281 | 0.150 |
Why?
|
| Interviews as Topic | 2 | 2016 | 137 | 0.150 |
Why?
|
| Psychotropic Drugs | 1 | 2018 | 28 | 0.150 |
Why?
|
| Behavioral Symptoms | 1 | 2018 | 15 | 0.150 |
Why?
|
| Odds Ratio | 2 | 2017 | 275 | 0.150 |
Why?
|
| Nursing Homes | 1 | 2018 | 37 | 0.150 |
Why?
|
| Brain | 3 | 2022 | 1697 | 0.150 |
Why?
|
| Socioeconomic Factors | 3 | 2014 | 312 | 0.150 |
Why?
|
| Social Environment | 1 | 2018 | 84 | 0.140 |
Why?
|
| Defecation | 1 | 2017 | 5 | 0.140 |
Why?
|
| Low Back Pain | 1 | 2019 | 121 | 0.140 |
Why?
|
| Starch | 1 | 2017 | 10 | 0.140 |
Why?
|
| Surveys and Questionnaires | 5 | 2016 | 1215 | 0.140 |
Why?
|
| Pain Management | 1 | 2019 | 147 | 0.140 |
Why?
|
| Microspheres | 1 | 2017 | 24 | 0.140 |
Why?
|
| Genetic Association Studies | 1 | 2017 | 86 | 0.140 |
Why?
|
| Dietary Fiber | 1 | 2017 | 25 | 0.140 |
Why?
|
| Prebiotics | 1 | 2017 | 25 | 0.140 |
Why?
|
| Invasive Fungal Infections | 1 | 2017 | 5 | 0.140 |
Why?
|
| Mucormycosis | 1 | 2017 | 9 | 0.140 |
Why?
|
| Frozen Sections | 1 | 2017 | 13 | 0.140 |
Why?
|
| Aspergillosis | 1 | 2017 | 13 | 0.140 |
Why?
|
| Birth Order | 1 | 2016 | 1 | 0.140 |
Why?
|
| Parity | 1 | 2016 | 2 | 0.140 |
Why?
|
| Reproductive Behavior | 1 | 2016 | 2 | 0.140 |
Why?
|
| Reproduction | 1 | 2016 | 10 | 0.140 |
Why?
|
| Iodide Peroxidase | 1 | 2018 | 112 | 0.140 |
Why?
|
| Quantitative Trait Loci | 1 | 2016 | 46 | 0.140 |
Why?
|
| Warfare | 1 | 2016 | 14 | 0.140 |
Why?
|
| Terrorism | 1 | 2016 | 14 | 0.130 |
Why?
|
| Inflammation | 1 | 2018 | 289 | 0.130 |
Why?
|
| Interview, Psychological | 2 | 2014 | 42 | 0.130 |
Why?
|
| Parkinson Disease | 2 | 2022 | 851 | 0.130 |
Why?
|
| Reading | 1 | 2016 | 42 | 0.130 |
Why?
|
| Brief Psychiatric Rating Scale | 1 | 2015 | 7 | 0.130 |
Why?
|
| Clinical Competence | 2 | 2015 | 243 | 0.120 |
Why?
|
| Overweight | 2 | 2014 | 77 | 0.120 |
Why?
|
| Self Report | 1 | 2016 | 226 | 0.120 |
Why?
|
| Carbohydrate Metabolism | 1 | 2015 | 4 | 0.120 |
Why?
|
| Carbohydrates | 1 | 2015 | 6 | 0.120 |
Why?
|
| Chromatography, Gas | 1 | 2015 | 11 | 0.120 |
Why?
|
| Insulin | 2 | 2014 | 90 | 0.120 |
Why?
|
| Urinalysis | 1 | 2015 | 9 | 0.120 |
Why?
|
| Models, Genetic | 1 | 2015 | 35 | 0.120 |
Why?
|
| Blood Glucose | 2 | 2014 | 109 | 0.120 |
Why?
|
| Health Status | 2 | 2014 | 229 | 0.120 |
Why?
|
| Adipose Tissue | 3 | 2005 | 79 | 0.120 |
Why?
|
| Anxiety Disorders | 1 | 2016 | 171 | 0.120 |
Why?
|
| Rhinitis | 1 | 2017 | 143 | 0.120 |
Why?
|
| Educational Measurement | 1 | 2015 | 59 | 0.120 |
Why?
|
| Sinusitis | 1 | 2017 | 162 | 0.120 |
Why?
|
| Demography | 1 | 2014 | 75 | 0.120 |
Why?
|
| Hospitalization | 2 | 2014 | 322 | 0.110 |
Why?
|
| Intelligence Tests | 1 | 2014 | 15 | 0.110 |
Why?
|
| Cats | 1 | 2014 | 29 | 0.110 |
Why?
|
| Hypoglycemia | 1 | 2014 | 13 | 0.110 |
Why?
|
| Models, Psychological | 1 | 2014 | 78 | 0.110 |
Why?
|
| Medicare | 1 | 2014 | 121 | 0.110 |
Why?
|
| Colitis, Ulcerative | 1 | 2014 | 64 | 0.110 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 354 | 0.110 |
Why?
|
| Mindfulness | 1 | 2014 | 48 | 0.110 |
Why?
|
| Ultrasonography | 1 | 2015 | 236 | 0.110 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2016 | 233 | 0.110 |
Why?
|
| Intestinal Mucosa | 1 | 2015 | 192 | 0.110 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2014 | 329 | 0.100 |
Why?
|
| Emergency Medicine | 1 | 2015 | 94 | 0.100 |
Why?
|
| Databases, Factual | 1 | 2014 | 358 | 0.100 |
Why?
|
| Urban Population | 1 | 2013 | 159 | 0.100 |
Why?
|
| Colonoscopy | 1 | 2013 | 74 | 0.100 |
Why?
|
| Diabetes Mellitus | 1 | 2014 | 137 | 0.100 |
Why?
|
| Adenoma | 1 | 2013 | 61 | 0.100 |
Why?
|
| Social Support | 1 | 2014 | 216 | 0.100 |
Why?
|
| Multicenter Studies as Topic | 1 | 2011 | 51 | 0.100 |
Why?
|
| Vascular Diseases | 1 | 2011 | 44 | 0.090 |
Why?
|
| Colorectal Neoplasms | 1 | 2013 | 113 | 0.090 |
Why?
|
| ROC Curve | 1 | 2011 | 145 | 0.090 |
Why?
|
| Gait | 1 | 2015 | 412 | 0.090 |
Why?
|
| Elder Abuse | 1 | 2011 | 36 | 0.090 |
Why?
|
| Breast Neoplasms | 3 | 2004 | 414 | 0.090 |
Why?
|
| Prostatic Neoplasms | 1 | 2011 | 104 | 0.090 |
Why?
|
| Frail Elderly | 1 | 2010 | 53 | 0.090 |
Why?
|
| Testosterone | 3 | 2004 | 28 | 0.090 |
Why?
|
| Self Care | 1 | 2010 | 105 | 0.080 |
Why?
|
| Computer Simulation | 1 | 2010 | 204 | 0.080 |
Why?
|
| Quality of Life | 1 | 2014 | 663 | 0.080 |
Why?
|
| Sensitivity and Specificity | 3 | 2017 | 519 | 0.070 |
Why?
|
| Femoracetabular Impingement | 1 | 2015 | 373 | 0.070 |
Why?
|
| Algorithms | 1 | 2010 | 378 | 0.070 |
Why?
|
| Common Cold | 1 | 2006 | 6 | 0.070 |
Why?
|
| Young Adult | 3 | 2018 | 2103 | 0.070 |
Why?
|
| C-Reactive Protein | 2 | 2018 | 105 | 0.060 |
Why?
|
| Animals | 1 | 2014 | 3808 | 0.060 |
Why?
|
| Pilot Projects | 2 | 2019 | 441 | 0.060 |
Why?
|
| Smoking Prevention | 1 | 2005 | 17 | 0.060 |
Why?
|
| Phenotype | 2 | 2016 | 309 | 0.060 |
Why?
|
| Feces | 2 | 2017 | 109 | 0.060 |
Why?
|
| Parent-Child Relations | 1 | 2005 | 40 | 0.060 |
Why?
|
| Observer Variation | 2 | 2015 | 104 | 0.060 |
Why?
|
| Peptide Hormones | 1 | 2004 | 3 | 0.060 |
Why?
|
| Diet, Reducing | 1 | 2004 | 12 | 0.060 |
Why?
|
| Smoking Cessation | 1 | 2005 | 48 | 0.060 |
Why?
|
| Sulfotransferases | 1 | 2004 | 6 | 0.060 |
Why?
|
| Androgens | 1 | 2004 | 8 | 0.060 |
Why?
|
| Glucuronosyltransferase | 1 | 2004 | 4 | 0.060 |
Why?
|
| Attitude to Health | 1 | 2005 | 106 | 0.060 |
Why?
|
| Double-Blind Method | 2 | 2017 | 425 | 0.060 |
Why?
|
| Metabolic Syndrome | 1 | 2005 | 62 | 0.060 |
Why?
|
| Estrogens | 1 | 2004 | 26 | 0.060 |
Why?
|
| Psychomotor Performance | 2 | 2018 | 214 | 0.060 |
Why?
|
| Parents | 1 | 2005 | 126 | 0.060 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2003 | 8 | 0.050 |
Why?
|
| Quercetin | 1 | 2022 | 13 | 0.050 |
Why?
|
| Kaempferols | 1 | 2022 | 12 | 0.050 |
Why?
|
| Eating | 1 | 2022 | 58 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2016 | 940 | 0.050 |
Why?
|
| Leisure Activities | 1 | 2022 | 15 | 0.050 |
Why?
|
| Memory, Short-Term | 1 | 2022 | 103 | 0.050 |
Why?
|
| Diet Surveys | 1 | 2021 | 26 | 0.050 |
Why?
|
| Logistic Models | 2 | 2013 | 399 | 0.050 |
Why?
|
| Washington | 3 | 2006 | 5 | 0.050 |
Why?
|
| Atrophy | 1 | 2021 | 91 | 0.050 |
Why?
|
| Tremor | 1 | 2022 | 117 | 0.040 |
Why?
|
| Autopsy | 1 | 2021 | 347 | 0.040 |
Why?
|
| Alcohol Drinking | 1 | 2020 | 81 | 0.040 |
Why?
|
| Smoking | 2 | 2015 | 181 | 0.040 |
Why?
|
| Memory | 2 | 2011 | 309 | 0.040 |
Why?
|
| Pain Threshold | 1 | 2019 | 21 | 0.040 |
Why?
|
| Hypertension | 1 | 2021 | 226 | 0.040 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2018 | 8 | 0.040 |
Why?
|
| Child | 2 | 2018 | 1424 | 0.040 |
Why?
|
| Military Personnel | 1 | 2019 | 40 | 0.040 |
Why?
|
| Neurotic Disorders | 1 | 2018 | 19 | 0.040 |
Why?
|
| Threonine | 1 | 2018 | 10 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2018 | 24 | 0.040 |
Why?
|
| Alanine | 1 | 2018 | 13 | 0.040 |
Why?
|
| Gene Frequency | 1 | 2018 | 61 | 0.040 |
Why?
|
| Community Health Planning | 1 | 2018 | 22 | 0.040 |
Why?
|
| Schizophrenia | 1 | 2018 | 68 | 0.040 |
Why?
|
| Awareness | 1 | 2018 | 45 | 0.040 |
Why?
|
| Bipolar Disorder | 1 | 2018 | 109 | 0.040 |
Why?
|
| Chronic Pain | 1 | 2019 | 114 | 0.040 |
Why?
|
| Fermentation | 1 | 2017 | 12 | 0.040 |
Why?
|
| Constipation | 1 | 2017 | 19 | 0.040 |
Why?
|
| Veterans | 1 | 2019 | 94 | 0.040 |
Why?
|
| Liver | 1 | 2018 | 160 | 0.040 |
Why?
|
| Fatty Acids, Volatile | 1 | 2017 | 36 | 0.040 |
Why?
|
| Mucor | 1 | 2017 | 5 | 0.040 |
Why?
|
| Aspergillus | 1 | 2017 | 7 | 0.040 |
Why?
|
| Educational Status | 1 | 2018 | 299 | 0.040 |
Why?
|
| Nasal Surgical Procedures | 1 | 2017 | 10 | 0.030 |
Why?
|
| Adolescent | 2 | 2018 | 2324 | 0.030 |
Why?
|
| Maternal Age | 1 | 2016 | 15 | 0.030 |
Why?
|
| Oncogene Protein v-akt | 1 | 2016 | 11 | 0.030 |
Why?
|
| Immunocompromised Host | 1 | 2017 | 45 | 0.030 |
Why?
|
| Gastrointestinal Tract | 1 | 2017 | 53 | 0.030 |
Why?
|
| Fertility | 1 | 2016 | 18 | 0.030 |
Why?
|
| Russia | 1 | 2016 | 4 | 0.030 |
Why?
|
| Jews | 1 | 2016 | 4 | 0.030 |
Why?
|
| Israel | 1 | 2016 | 17 | 0.030 |
Why?
|
| Emigration and Immigration | 1 | 2016 | 16 | 0.030 |
Why?
|
| Nose | 1 | 2017 | 36 | 0.030 |
Why?
|
| Arabs | 1 | 2016 | 9 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 44 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2018 | 604 | 0.030 |
Why?
|
| Acute Disease | 1 | 2017 | 207 | 0.030 |
Why?
|
| Sleep | 1 | 2019 | 356 | 0.030 |
Why?
|
| Ankle | 1 | 2015 | 24 | 0.030 |
Why?
|
| Gallbladder | 1 | 2015 | 4 | 0.030 |
Why?
|
| Anatomic Landmarks | 1 | 2015 | 5 | 0.030 |
Why?
|
| Pregnancy | 1 | 2016 | 340 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2019 | 298 | 0.030 |
Why?
|
| Endoscopy | 1 | 2017 | 182 | 0.030 |
Why?
|
| Chromosomes, Human | 1 | 2015 | 7 | 0.030 |
Why?
|
| Knee | 1 | 2015 | 46 | 0.030 |
Why?
|
| Kidney Function Tests | 1 | 2015 | 22 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 2015 | 42 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2015 | 44 | 0.030 |
Why?
|
| Intestinal Absorption | 1 | 2015 | 37 | 0.030 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2017 | 184 | 0.030 |
Why?
|
| Decision Making | 1 | 2017 | 229 | 0.030 |
Why?
|
| Hip | 1 | 2015 | 65 | 0.030 |
Why?
|
| Permeability | 1 | 2015 | 119 | 0.030 |
Why?
|
| Kinetics | 1 | 2015 | 185 | 0.030 |
Why?
|
| China | 1 | 2014 | 52 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2014 | 3615 | 0.030 |
Why?
|
| Leukocyte L1 Antigen Complex | 1 | 2014 | 8 | 0.030 |
Why?
|
| Body Weight | 2 | 2004 | 145 | 0.030 |
Why?
|
| Interleukins | 1 | 2014 | 25 | 0.030 |
Why?
|
| Estrone | 2 | 2004 | 8 | 0.030 |
Why?
|
| Sex Hormone-Binding Globulin | 2 | 2004 | 16 | 0.030 |
Why?
|
| Point-of-Care Systems | 1 | 2015 | 61 | 0.030 |
Why?
|
| Hydrocortisone | 1 | 2014 | 40 | 0.030 |
Why?
|
| Estradiol | 2 | 2004 | 41 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2015 | 121 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 177 | 0.030 |
Why?
|
| Acute Kidney Injury | 1 | 2014 | 46 | 0.030 |
Why?
|
| Radiography | 1 | 2015 | 652 | 0.030 |
Why?
|
| Patient Compliance | 2 | 2005 | 165 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 146 | 0.030 |
Why?
|
| Biomechanical Phenomena | 1 | 2015 | 676 | 0.030 |
Why?
|
| Attention | 1 | 2014 | 139 | 0.030 |
Why?
|
| Critical Illness | 1 | 2014 | 134 | 0.030 |
Why?
|
| Medical Record Linkage | 1 | 2011 | 1 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2013 | 105 | 0.020 |
Why?
|
| Range of Motion, Articular | 1 | 2015 | 725 | 0.020 |
Why?
|
| Length of Stay | 1 | 2014 | 329 | 0.020 |
Why?
|
| Perception | 1 | 2011 | 77 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2014 | 294 | 0.020 |
Why?
|
| Risk | 1 | 2011 | 209 | 0.020 |
Why?
|
| Cross Infection | 1 | 2014 | 282 | 0.020 |
Why?
|
| Trail Making Test | 1 | 2010 | 4 | 0.020 |
Why?
|
| Wechsler Scales | 1 | 2010 | 10 | 0.020 |
Why?
|
| Epidemiologic Research Design | 1 | 2010 | 16 | 0.020 |
Why?
|
| Psychometrics | 1 | 2010 | 244 | 0.020 |
Why?
|
| Caregivers | 1 | 2011 | 201 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2010 | 674 | 0.020 |
Why?
|
| Influenza Vaccines | 1 | 2006 | 11 | 0.020 |
Why?
|
| Respiratory Tract Infections | 1 | 2006 | 25 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 993 | 0.020 |
Why?
|
| Leptin | 1 | 2005 | 22 | 0.020 |
Why?
|
| Health Education | 1 | 2005 | 54 | 0.020 |
Why?
|
| Ghrelin | 1 | 2004 | 2 | 0.020 |
Why?
|
| Triglycerides | 1 | 2005 | 57 | 0.020 |
Why?
|
| Body Size | 1 | 2004 | 13 | 0.010 |
Why?
|
| Homeostasis | 1 | 2005 | 69 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2005 | 52 | 0.010 |
Why?
|
| Arylsulfotransferase | 1 | 2004 | 1 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 2004 | 17 | 0.010 |
Why?
|
| Body Composition | 1 | 2005 | 69 | 0.010 |
Why?
|
| Receptors, Progesterone | 1 | 2004 | 25 | 0.010 |
Why?
|
| Energy Intake | 1 | 2004 | 83 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2004 | 59 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 2004 | 61 | 0.010 |
Why?
|
| New Mexico | 1 | 2003 | 3 | 0.010 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 2003 | 5 | 0.010 |
Why?
|
| Anthropometry | 1 | 2003 | 36 | 0.010 |
Why?
|
| Absorptiometry, Photon | 1 | 2003 | 82 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2003 | 372 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2004 | 772 | 0.010 |
Why?
|